In the new year, preparations have been made to approve the emergency use of Oxford AstraZeneca vaccine Covishield before a dry run of the Corona virus vaccine from January 2 across the country. Let us know that all the tests were being conducted in India through the serum institute regarding Covishield. However, sources were quoted as saying that the recommendation was made after deliberating with the Union Health Minister Dr Harsh Vardhan on the approval of the expert committee meeting of CDSCO on Friday.
As part of this recommendation, Covishield, an anti-Kovid-19 vaccine from Oxford, is set to approve emergency use in India. In fact, the expert committee of CDSCO has approved the approval of Covishield. Now the Drug Controller General of India (DGCI) will work on the final approval after considering this approval. If this happens, it will become the first vaccine to be approved for emergency use in the country. The Central Government is already preparing for the rehearsal of vaccination.
Meanwhile, sources say that the committee’s meeting is still going on. Presentation of Bharat Biotech is still going on. According to a statement from the Ministry of Health, before the DCGI, the committee will make its recommendations by taking appropriate decisions. After this, the decision of DCGI will be the final decision. Let us know that after the increase in corona cases in the country last year, DCGI changed its rules related to approving drugs and made them more strict.